
Ganapathy Krishnan
Examiner (ID: 18545)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1654 |
| Issued Applications | 795 |
| Pending Applications | 189 |
| Abandoned Applications | 704 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17561672
[patent_doc_number] => 20220125821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => CYCLIC DINUCLEOTIDE PRODRUG MOLECULE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/422137
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422137 | Cyclic dinucleotide prodrug molecule, preparation method therefor and application thereof | Jan 9, 2020 | Issued |
Array
(
[id] => 15863123
[patent_doc_number] => 20200138965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => CONJUGATE OF GINSENOSIDE COMPOUND K AND GLYCOL CHITOSAN AND AN ANTI-TUMOR USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/733840
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733840 | Conjugate of ginsenoside compound K and glycol chitosan and an anti-tumor use thereof | Jan 2, 2020 | Issued |
Array
(
[id] => 17541046
[patent_doc_number] => 11306157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly
[patent_app_type] => utility
[patent_app_number] => 16/723959
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 31846
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723959 | Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly | Dec 19, 2019 | Issued |
Array
(
[id] => 16893182
[patent_doc_number] => 11034715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Ectonucleotidase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/720369
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54500
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720369 | Ectonucleotidase inhibitors and methods of use thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16900943
[patent_doc_number] => 20210179859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => GRAPHENE-CYCLODEXTRIN COMPLEX AND ITS USE IN CORROSION PREVENTION
[patent_app_type] => utility
[patent_app_number] => 16/717484
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717484 | Graphene-cyclodextrin complex and its use in corrosion prevention | Dec 16, 2019 | Issued |
Array
(
[id] => 19778512
[patent_doc_number] => 12227536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Crystalline forms of an NRTTI compound
[patent_app_type] => utility
[patent_app_number] => 17/415570
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12360
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415570
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415570 | Crystalline forms of an NRTTI compound | Dec 15, 2019 | Issued |
Array
(
[id] => 16009153
[patent_doc_number] => 20200179419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => METHOD FOR THE MANUFACTURE AND USE OF A BIONIC HYDROGEL COMPOSITION FOR MEDICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/710301
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710301 | Method for the manufacture and use of a bionic hydrogel composition for medical applications | Dec 10, 2019 | Issued |
Array
(
[id] => 16451095
[patent_doc_number] => 20200360521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/710711
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 465
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710711
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710711 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | Dec 10, 2019 | Abandoned |
Array
(
[id] => 16295518
[patent_doc_number] => 20200281241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => INTESTINAL BARRIER INTEGRITY
[patent_app_type] => utility
[patent_app_number] => 16/706725
[patent_app_country] => US
[patent_app_date] => 2019-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706725 | Intestinal barrier integrity | Dec 6, 2019 | Issued |
Array
(
[id] => 16295518
[patent_doc_number] => 20200281241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => INTESTINAL BARRIER INTEGRITY
[patent_app_type] => utility
[patent_app_number] => 16/706725
[patent_app_country] => US
[patent_app_date] => 2019-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706725 | Intestinal barrier integrity | Dec 6, 2019 | Issued |
Array
(
[id] => 15862869
[patent_doc_number] => 20200138838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => COMPOSITION COMPRISING HMSS/HMOS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/706627
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706627 | COMPOSITION COMPRISING HMSS/HMOS AND USE THEREOF | Dec 5, 2019 | Abandoned |
Array
(
[id] => 17533704
[patent_doc_number] => 20220112313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ULTRASONIC-ASSISTED METHOD OF EXTRACTING A PECTIN RICH IN RG-I
[patent_app_type] => utility
[patent_app_number] => 17/267489
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267489 | Ultrasonic-assisted method of extracting a pectin rich in RG-I | Dec 2, 2019 | Issued |
Array
(
[id] => 15649611
[patent_doc_number] => 20200087335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => PROCESSES FOR PREPARING MACROLIDES AND KETOLIDES AND INTERMEDIATES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/693978
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693978 | PROCESSES FOR PREPARING MACROLIDES AND KETOLIDES AND INTERMEDIATES THEREFOR | Nov 24, 2019 | Abandoned |
Array
(
[id] => 15646465
[patent_doc_number] => 20200085762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => Nutritional Compositions Containing An Elevated Level Of Inositol And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/693738
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693738
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693738 | Nutritional Compositions Containing An Elevated Level Of Inositol And Uses Thereof | Nov 24, 2019 | Abandoned |
Array
(
[id] => 16389710
[patent_doc_number] => 20200330651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
[patent_app_type] => utility
[patent_app_number] => 16/691073
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691073 | ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN | Nov 20, 2019 | Abandoned |
Array
(
[id] => 17657043
[patent_doc_number] => 20220177508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/294918
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294918 | C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof | Nov 17, 2019 | Pending |
Array
(
[id] => 17334561
[patent_doc_number] => 20220000892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => INFANT NUTRITIONAL COMPOSITION FOR USE IN THE ENHANCEMENT OF PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/296588
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296588 | INFANT NUTRITIONAL COMPOSITION FOR USE IN THE ENHANCEMENT OF PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS | Oct 31, 2019 | Pending |
Array
(
[id] => 17334561
[patent_doc_number] => 20220000892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => INFANT NUTRITIONAL COMPOSITION FOR USE IN THE ENHANCEMENT OF PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/296588
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296588 | INFANT NUTRITIONAL COMPOSITION FOR USE IN THE ENHANCEMENT OF PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS | Oct 31, 2019 | Pending |
Array
(
[id] => 17342120
[patent_doc_number] => 20220008451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => FLAVIN ADENINE DINUCLEOTIDE (FAD) FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/289221
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289221 | FLAVIN ADENINE DINUCLEOTIDE (FAD) FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER | Oct 30, 2019 | Pending |
Array
(
[id] => 17342120
[patent_doc_number] => 20220008451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => FLAVIN ADENINE DINUCLEOTIDE (FAD) FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/289221
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289221 | FLAVIN ADENINE DINUCLEOTIDE (FAD) FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER | Oct 30, 2019 | Pending |